方法单独使用维思通治疗连续住院的首发精神分裂症12周，用BPRS和TESS量表评定疗效和副反应。
Method Patients with first-onset schizophrenia were treated with risperidone for 12 weeks, and assessed with BPRS and TESS for the efficacy and side effect.
方法用奥氮平治疗首发精神分裂症32例，疗程8周；用简明精神病评定量表(BPRS)和副反应量表(TESS)评定疗效及副反应。
Method: 32 patients with first episode schizophrenia were treated with olanzapine for 8 weeks, and assessed with BPRS and TESS for the efficacy and safety.
用简明精神症状量表(BPRS)和药物副反应量表(TESS)评定疗效和副反应，治疗结束后随访两年。
The brief psychiatric rating scale (BPRS) was used to evaluate the effect, treatment emergent symptom scale (TESS) to evaluate side effects, and all the patients were followed up for 2 years.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
应用推荐